Anti-inflammatory drugs in experimental atherosclerosis
- 1 April 1989
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 76 (2-3) , 155-161
- https://doi.org/10.1016/0021-9150(89)90099-3
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Formation of 15-hydroxyeicosatetraenoic acid (15-HETE) as the predominant eicosanoid in aortas from Watanabe Heritable Hyperlipidemic and cholesterol-fed rabbitsAtherosclerosis, 1988
- Is atherosclerosis a complication of long-term corticosteroid treatment?The American Journal of Medicine, 1986
- The Pathogenesis of Atherosclerosis — An UpdateNew England Journal of Medicine, 1986
- The Role of Arachidonic Acid Oxygenation Products in Pain and InflammationAnnual Review of Immunology, 1984
- Defective Lipoprotein Receptors and AtherosclerosisNew England Journal of Medicine, 1983
- Delayed clearance of very low density and intermediate density lipoproteins with enhanced conversion to low density lipoprotein in WHHL rabbits.Proceedings of the National Academy of Sciences, 1982
- Serial inbreeding of rabbits with hereditary hyperlipidemia (WHHL-rabbit) *1Incidence and development of atherosclerosis and xanthomaAtherosclerosis, 1980
- Anti-inflammatory drugs in experimental atherosclerosis Part 3. Evaluation of the atherogenicity of homocystine in rabbitsAtherosclerosis, 1978
- Anti-inflammatory drugs in experimental atherosclerosis Part 1. Relative potencies for inhibiting plaque formationAtherosclerosis, 1973